GLP-1 receptor agonists are a gamechanger in obesity care, but researchers are still working to better understand their ...
Researchers created a human spinal cord organoid, injured it, then applied an experimental therapy. What happened next was ...
BACKGROUND: Genetic variants in components or regulators of the RAS-MAPK signaling pathway are causative for severe and early-onset hypertrophic cardiomyopathy (HCM) in patients with Noonan syndrome ...
NEWARK, CA / ACCESS Newswire / April 16, 2026 / Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on April 15, 2026, it issued inducement awards to two recently hired employees in accor ...
Accurate measurement of HMGB-1, neopterin and sIL-2R supports reliable assessment of immune activation across clinical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results